Comparative statistics by cancer registry

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group

(Seoul, South Korea, 1993-1997 cases followed-up until 2001)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	No. of cases	Male			Female			Number of cases by age group					Relative survival by age group
			5-year survival			5-year survival			Number of cases by age group					Relative survival by age group
			No.	Abs	Rel	No.	Abs	Rel	<45	45-54	55-64	65-74	75+	<45	45-54	55-64	65-74	75+
C00	Lip	26	14	50.0	65.0	12	50.0	58.8	2	3	4	6	11	100.5	33.9	82.3	78.5	44.3
C01-02	Tongue	243	163	52.5	59.8	80	58.3	63.4	39	53	74	49	28	83.1	60.4	55.7	45.5	77.0
C03-06	Oral cavity	303	221	38.8	44.1	82	64.2	67.7	50	59	97	64	33	83.0	43.5	47.0	42.9	38.3
C07-08	Salivary gland	194	109	54.9	60.2	85	76.3	79.4	62	54	42	23	13	84.4	63.0	72.0	35.2	64.5
C09	Tonsil	92	74	50.0	55.1	18	60.7	63.9	13	25	29	19	6	85.8	58.3	59.2	31.5	51.3
C10	Other oropharynx	52	42	33.3	36.4	10	30.0	32.6	8	13	11	13	7	63.3	32.0	49.0	28.1	0.0
C11	Nasopharynx	278	204	37.5	40.4	74	60.8	62.4	98	72	64	32	12	57.7	54.4	23.2	41.6	37.1
C12-13	Hypopharynx	170	159	24.3	28.7	11	36.4	37.8	5	33	59	57	16	40.8	35.0	24.2	29.0	38.2
C15	Oesophagus	1134	995	15.5	17.8	139	25.9	28.9	24	169	448	336	157	42.2	19.7	23.0	15.1	12.5
C16	Stomach	16180	10439	43.1	48.5	5741	42.7	45.9	2728	3154	4715	3769	1814	52.7	55.5	50.9	41.0	29.7
C17	Small intestine	242	143	27.9	31.2	99	33.0	35.2	45	44	70	55	28	42.8	37.6	36.7	24.2	16.0
C18	Colon	3720	1985	59.4	68.5	1735	53.8	59.1	478	702	1059	948	533	69.5	67.3	67.4	62.2	51.0
C19-20	Rectum	3715	2091	52.9	60.3	1624	56.0	60.9	495	774	1119	895	432	59.8	63.0	62.9	60.6	52.0
C21	Anus	313	138	21.5	26.1	175	33.1	37.2	39	60	73	68	73	20.7	37.4	35.0	36.4	27.5
C22	Liver	9872	7553	16.9	18.7	2319	19.4	20.8	1309	2918	3159	1802	684	25.3	18.8	18.8	18.3	13.1
C23-24	Gall bladder	2293	1127	24.3	28.5	1166	21.8	24.4	151	346	662	668	466	42.9	30.0	26.5	23.9	22.0
C25	Pancreas	1807	993	11.8	13.8	814	14.7	16.3	138	273	544	521	331	32.7	17.1	10.7	14.9	13.4
C26	Gastrointestinal tract unspecified	58	35	16.9	20.1	23	30.4	35.4	7	6	14	18	13	14.4	48.9	15.6	32.9	24.4
C30-31	Nose/Sinuses	224	142	40.8	45.3	82	54.6	59.0	53	60	55	37	19	46.7	49.9	44.9	60.4	61.4
C32	Larynx	791	717	62.5	73.0	74	52.3	59.9	33	131	302	214	111	80.0	79.9	71.6	74.4	53.8
C33-34	Lung	8482	6197	15.4	18.1	2285	17.5	19.5	482	1218	2504	2788	1490	23.5	23.6	20.1	15.8	14.9
C37-38	Other thoracic organs	226	138	42.6	45.6	88	52.1	55.3	86	38	41	44	17	64.3	54.7	37.0	37.4	16.6
C40-41	Bone	343	200	43.7	45.7	143	49.9	51.3	227	30	42	27	17	52.0	58.5	47.9	9.0	38.1
C43	Melanoma skin	179	87	40.7	45.1	92	55.0	60.0	42	40	49	28	20	37.2	56.6	60.9	50.0	66.5
C44	Other skin	618	328	75.8	88.6	290	84.8	98.4	113	94	131	149	131	86.8	90.1	93.7	98.7	97.0
C45	Mesothelioma	52	32	37.5	39.9	20	45.0	49.0	13	14	12	8	5	46.8	44.4	44.2	30.2	53.7
C47+C49	Connective tissue	484	261	50.6	54.5	223	57.6	60.3	227	78	77	64	38	61.5	65.9	54.2	45.1	35.5
C48	Peritoneum	160	82	42.1	44.5	78	34.5	35.9	61	34	35	20	10	50.7	32.9	40.0	41.4	0.0
C50	Breast	5355	35	60.0	68.7	5320	77.8	79.9	2107	1814	922	387	125	81.6	82.0	77.7	71.3	56.5
C51	Vulva	55				55	60.0	66.4	10	8	11	19	7	60.4	63.5	84.7	59.1	68.0
C52	Vagina	46				46	67.2	71.1	10	11	11	9	5	80.4	72.8	85.3	64.0	26.7
C53	Cervix	5357				5357	75.7	78.7	1794	1373	1262	711	217	87.1	79.4	75.4	68.3	52.9
C54	Corpus uteri	522				522	81.8	84.7	158	169	126	51	18	90.9	88.3	78.9	72.4	71.4
C55	Uterus unspecified	87				87	73.6	76.4	35	21	13	12	6	77.6	82.2	95.9	57.0	45.5
C56	Ovary	1305				1305	64.2	66.2	572	287	242	139	65	81.5	64.1	52.2	44.1	35.5
C57	Other female genital	85				85	41.2	43.2	26	22	17	15	5	54.2	46.2	42.7	21.8	33.1
C58	Placenta	113				113	92.8	93.3	99	13	1	0	0	94.2	85.9	102.7	0.0	0.0
C60	Penis	43	43	64.9	82.2				4	6	11	11	11	101.8	69.4	50.4	89.7	112.2
C61	Prostate	948	948	53.5	72.8				9	25	193	365	356	33.7	57.7	74.0	71.2	77.3
C62	Testis	106	106	91.5	93.7				90	8	3	4	1	91.8	104.5	109.9	91.9	150.5
C64	Kidney	1177	781	61.2	68.0	396	66.5	70.6	240	258	353	229	97	80.9	75.8	68.7	58.3	42.6
C65	Renal pelvis	147	103	70.6	81.6	44	52.3	59.5	10	29	44	51	13	61.0	64.5	81.4	73.8	96.8
C66	Ureter	104	70	52.1	62.0	34	58.8	64.8	3	21	29	36	15	34.1	44.2	74.8	69.6	57.2
C67	Urinary bladder	1930	1595	65.4	77.6	335	58.6	66.8	184	302	541	516	387	92.7	84.9	76.8	75.0	57.3
C68	Other urinary organs	64	33	36.1	49.0	31	32.3	36.4	3	7	16	14	24	33.6	59.0	40.4	50.4	35.8
C69	Eye	93	58	69.0	72.1	35	65.7	67.8	62	12	12	3	4	69.7	60.4	98.6	0.0	79.5
C70-72	Brain & nervous system	1163	643	37.5	38.9	520	41.3	42.2	651	169	205	106	32	51.9	34.7	25.0	14.3	14.0
C73	Thyroid	2657	416	84.2	90.2	2241	93.0	95.5	1348	560	424	234	91	99.6	97.1	93.1	79.9	44.7
C74	Adrenal gland	87	50	41.0	42.2	37	40.4	40.8	62	10	11	3	1	43.0	51.8	39.7	0.0	0.0
C75	Other endocrine	78	56	62.5	64.9	22	63.3	64.3	53	6	10	4	5	73.7	86.4	54.4	0.0	0.0
C81	Hodgkin lymphoma	133	75	63.6	66.9	58	81.0	84.1	76	20	17	17	3	83.3	72.4	50.7	62.8	57.3
C82-85+C96	Non-Hodgkin lymphoma	1680	986	50.8	54.9	694	57.2	60.0	608	335	378	264	95	62.6	58.8	56.0	46.4	49.5
C90	Multiple myeloma	347	196	24.7	28.0	151	31.0	32.7	39	71	111	95	31	56.7	27.1	30.1	27.4	7.6
C91	Lymphoid leukaemia	595	343	37.4	38.1	252	47.9	48.4	483	34	33	36	9	46.1	18.1	25.2	39.2	14.2
C92-94	Myeloid leukaemia	1219	671	26.8	27.9	548	24.5	25.0	701	187	178	113	40	33.1	20.9	20.9	10.4	7.2
C95	Leukaemia unspecified	80	40	12.5	13.2	40	16.9	17.2	41	10	10	10	9	29.4	0.0	0.0	0.0	0.0

Graphs:

5-year absolute survival for male

5-year relative survival for male

5-year absolute survival for female

5-year relative survival for female

5-year relative survival by age group: -45

5-year relative survival by age group: 45-54

5-year relative survival by age group: 55-64

5-year relative survival by age group: 65-74

5-year relative survival by age group: +75

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Seoul, South Korea, 1993-1997 cases followed-up until 2001)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)

Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group